Epidemiological Study of Hospitalized Children for Pulmonary Tuberculosis at Strasbourg University Hospitals

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Oct 25, 2023

Keywords

ClinConnect Summary

This clinical trial is studying pulmonary tuberculosis, a serious lung infection that primarily affects children. The researchers want to find out how common this condition is among children who were hospitalized at Strasbourg University Hospitals from 2012 to 2022. They are also looking into what factors might increase the risk of a child getting tuberculosis and how the disease shows up in different children. This is important because, although tuberculosis is rare in children in France, it still poses risks, especially for those who live with someone infected or have other health issues.

To be eligible for this study, a child must be between 1 and 17 years old and have been hospitalized for pulmonary tuberculosis during the specified time frame. Additionally, their parents or guardians must agree to allow the use of their child’s medical data for research. Participants in this study can expect that their health information will be reviewed to help researchers better understand and combat this illness. Overall, the findings from this trial could help improve care for children with tuberculosis in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Child (1 to 17 years old)
• • Child hospitalized for pulmonary tuberculosis at Strasbourg University Hospital between January 1, 2012 and December 31, 2022.
• • Child and/or his/her parental authority who have not expressed their opposition to the reuse of data for scientific research purposes.
• Exclusion Criteria:
• • - Subject and/or their parental authority having expressed their opposition to the re-use of the child's data for scientific research purposes.